A detailed history of Bank Of Montreal transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Bank Of Montreal holds 105,247 shares of RPTX stock, worth $312,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,247
Previous 110,935 5.13%
Holding current value
$312,583
Previous $366,000 1.09%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.75 - $3.99 $15,642 - $22,695
-5,688 Reduced 5.13%
105,247 $362,000
Q2 2024

Aug 14, 2024

BUY
$3.02 - $4.7 $17,132 - $26,663
5,673 Added 5.39%
110,935 $366,000
Q1 2024

May 13, 2024

BUY
$4.53 - $8.41 $1,359 - $2,523
300 Added 0.29%
105,262 $495,000
Q4 2023

Feb 08, 2024

SELL
$3.22 - $11.79 $3,751 - $13,735
-1,165 Reduced 1.1%
104,962 $766,000
Q3 2023

Nov 01, 2023

SELL
$8.16 - $13.01 $95,447 - $152,177
-11,697 Reduced 9.93%
106,127 $1.28 Million
Q2 2023

Aug 02, 2023

SELL
$8.63 - $12.53 $94,955 - $137,867
-11,003 Reduced 8.54%
117,824 $1.25 Million
Q1 2023

Jun 13, 2024

BUY
$9.32 - $15.06 $210,305 - $339,828
22,565 Added 21.44%
127,827 $1.26 Million
Q4 2022

Feb 01, 2023

SELL
$12.5 - $18.13 $63,350 - $91,882
-5,068 Reduced 3.79%
128,827 $1.9 Million
Q3 2022

Nov 10, 2022

SELL
$11.57 - $15.59 $45,817 - $61,736
-3,960 Reduced 2.87%
133,895 $1.68 Million
Q2 2022

Aug 11, 2022

SELL
$8.45 - $14.84 $6,759 - $11,872
-800 Reduced 0.58%
137,855 $1.94 Million
Q1 2022

May 12, 2022

BUY
$11.38 - $21.88 $557 - $1,072
49 Added 0.04%
138,655 $2 Million
Q4 2021

Feb 11, 2022

SELL
$19.66 - $28.11 $288,648 - $412,711
-14,682 Reduced 9.58%
138,606 $3.04 Million
Q3 2021

Nov 12, 2021

SELL
$25.71 - $35.24 $1.19 Million - $1.62 Million
-46,100 Reduced 23.12%
153,288 $4.39 Million
Q2 2021

Aug 12, 2021

BUY
$30.1 - $34.85 $6 Million - $6.95 Million
199,388 New
199,388 $6.78 Million

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $125M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.